Very interesting, kingpin. $3.8M of new funding to take Disruption to the next level, which begs the question who those strategic partners will be..
“Disruption Labs core strategy is a B2B business model, working in partnership with multi-national corporations and high-growth SMEs [small to mid-size enteprise] in the functional food & beverage and clinical therapeutic markets to improve or bio-enhance existing products areas, or create entirely new disruptive products.”
- - - - - -
Disruption Labs, the parent company to CBD company Reset Biosciences closed a $3.8 million seed round led by Andrew Garnock/AJR Consulting, a family office that has previously invested in the medical cannabis space.